Vanderbilt University School of
Brandt, Stephen J. , M.D.
Professor of Medicine
Professor of Cell and Developmental Biology
Professor of Cancer Biology
Phone Number: 615-936-1809
540B (office) and 540-542 (lab) PRB
777 Preston Research Building, 2220 Pierce Avenue, Nashville, TN 37232-6307 37232-6307
Transcriptional regulation; basic helix-loop-helix transcription factors; LIM domain proteins; protein dimerization; cell differentiation; hematopoiesis; T-cell leukemia
Our research focuses on the control of blood cell production and how this is subverted in hematologic malignancy. We have been particularly interested in the oncogene TAL1 (or SCL) that encodes a member of the helix-loop-helix family of transcription factors. Abnormal expression of this gene, originally identified through its involvement by a recurrent chromosomal translocation, constitutes the most frequent gain-of-function mutation in T-cell acute lymphoblastic leukemia (T-ALL). Many helix-loop-helix proteins are important in specification of cell fate, and studies from our lab and others indicate that TAL1 regulates fundamental aspects of hematopoietic differentiation.
We have characterized in detail the expression of TAL1 protein in murine and avian embryogenesis and, most recently, in physiological and pathological vasculogenesis. A series of studies on TAL1 function in erythroid cells have shown this transcription factor undergoes both phosphorylation and acetylation, and we have investigated its interaction with a number of transcriptional coregulators. Work is ongoing to investigate the mechanism by which misexpression of this critical regulator of normal hematopoiesis contributes to leukemic transformation and to identify both its interaction partners and downstream targets. Contemporary techniques of molecular biology and protein biochemistry and both in vitro and in vivo models are used in this research.
Leukemias; Lymphomas; Multiple Myeloma
Dey, S, Curtis, DJ, Jane, SM, Brandt, SJ. The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors. Mol Cell Biol, 30(9), 2181-92, 2010.
Wang Y, Klumpp S, Amin HM, Liang H, Li J, Estrov Z, Zweidler-McKay P, Brandt SJ, Agulnick A, and Nagarajan L. SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability. Oncogene, 29, 3044-3053, 2010.
Brandt SJ and Koury MJ. Regulation of LMO2 mRNA and protein expression in erythroid differentiation. Haematologica, 94, 447-448, 2009.
Cai, Y, Xu, Z, Xie, J, Ham, AJ, Koury, MJ, Hiebert, SW, Brandt, SJ. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors. Biochem Biophys Res Commun, 390(2), 295-301, 2009.
Hamid, R, Brandt, SJ. Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells. Mol Oncol, 3(5-6), 451-63, 2009.
Brandt, SJ. GATA-1: one TEF customer. Blood, 112(13), 4786-7, 2008.
Cai, Y, Xu, Z, Nagarajan, L, Brandt, SJ. Single-stranded DNA-binding proteins regulate the abundance and function of the LIM-homeodomain transcription factor LHX2 in pituitary cells. Biochem Biophys Res Commun, 373(2), 303-8, 2008. PMCID:2496924
Hamid, R, Patterson, J, Brandt, SJ. Genomic structure, alternative splicing and expression of TG-interacting factor, in human myeloid leukemia blasts and cell lines. Biochim Biophys Acta, 1779(5), 347-55, 2008. PMCID:2367313
Odenike OM, Alkan S, Dorie S, Godwin JE, Huo D, Brandt SJ, Green M, Xie J, Zhang Y, Vesole DH, Stiff P, Wright J, Larson RA, Stock W, the University of Chicago Phase II Consortium. The histone deacetylase inhibitor depsipeptide has differential activity in Core Binding Factor acute myeloid leukemia. Clin. Cancer Res., 14, 7095-7101, 2008.
Xie, J, Crooke, PS, McKinney, BA, Soltman, J, Brandt, SJ. A computational model of quantitative chromatin immunoprecipitation (ChIP) analysis. Cancer Inform, 6, 138-46, 2008. PMCID:2367313
Engelhardt, BG, Holland, DW, Brandt, SJ, Chinratanalab, W, Goodman, SA, Greer, JP, Jagasia, MH, Kassim, AA, Morgan, DS, Ruffner, KL, Schuening, FG, Wolff, S, Bitting, R, Sulur, P, Stein, RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk Lymphoma, 48(9), 1728-35, 2007. PMCID:2367313
Xu, Z, Meng, X, Cai, Y, Liang, H, Nagarajan, L, Brandt, SJ. Single-stranded DNA-binding proteins regulate the abundance of LIM domain and
LIM domain-binding proteins. Genes Dev, 21(8), 942-55, 2007. PMCID:1847712
Yang, G, Thompson, MA, Brandt, SJ, Hiebert, SW. Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion
oncoprotein. Oncogene, 26(1), 91-101, 2007.
Pimanda, JE, Silberstein, L, Dominici, M, Dekel, B, Bowen, M, Oldham, S, Kallianpur, A, Brandt, SJ, Tannahill, D, G??ttgens, B, Green, AR. Transcriptional link between blood and bone: the stem cell leukemia gene and
its +19 stem cell enhancer are active in bone cells. Mol Cell Biol, 26(7), 2615-25, 2006. PMCID:1430329
Reed-Inderbitzin, E, Moreno-Miralles, I, Vanden-Eynden, SK, Xie, J, Lutterbach, B, Durst-Goodwin, KL, Luce, KS, Irvin, BJ, Cleary, ML, Brandt, SJ, Hiebert, SW. RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription. Oncogene, 25, 5777-5786, 2006.
Tang, T, Shi, Y, Opalenik, SR, Brantley-Sieders, DM, Chen, J, Davidson, JM, Brandt, SJ. Expression of the TAL1/SCL transcription factor in physiological and pathological vascular processes. J Pathol, 210(1), 121-9, 2006. PMCID:1847712
Tran YH, Xu Z, Kato A, Mistry AC, Goya Y, Taira M, Brandt SJ, and Hirose S. Spliced isoforms of LIM-domain-binding protein (CLIM/NLI/Ldb) lacking LIM-interaction domain. J. Biochem., 140, 105-119, 2006.
Xu, Z, Meng, X, Cai, Y, Koury, MJ, Brandt, SJ. Recruitment of the SWI/SNF protein Brg1 by a multiprotein complex effects transcriptional
repression in murine erythroid progenitors. Biochem J, 399(2), 297-304, 2006. PMCID:1609906
Linggi, BE, Brandt, SJ, Sun, ZW, Hiebert, SW. Translating the histone code into leukemia. J Cell Biochem, 96(5), 938-50, 2005.
Thompson, MA, Stumph, J, Henrickson, SE, Rosenwald, A, Wang, Q, Olson, S, Brandt, SJ, Roberts, J, Zhang, X, Shyr, Y, Kinney, MC. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic
lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol, 36(5), 494-504, 2005.
Wen, J, Huang, S, Pack, SD, Yu Y, Brandt, SJ, Noguchi, CT. Tal1/SCL binding to pericentromeric DNA represses transcription. J Biol Chem, 280(13), 12956-66, 2005.
Xu, Z, Huang, S, Chang, LS, Agulnick, AD, Brandt, SJ. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding
protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol, 23(21), 7585-99, 2003. PMCID:207591
Koury, MJ, Sawyer, ST, Brandt, SJ. New insights into erythropoiesis. Curr Opin Hematol, 9(2), 93-100, 2002.
Tang, T, Arbiser, JL, Brandt, SJ. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced
turnover of the TAL1/SCL transcription factor in endothelial cells. J Biol Chem, 277(21), 18365-72, 2002.
Brandt SJ: Role of the TAL1/SCL Transcription Factor In Normal and Leukemic Hematopoiesis, in Transcription Factors: Normal and Malignant Development of Blood Cells, Ravid K and Licht J (eds.), J Wiley & Sons, 2000
Huang, S, Brandt, SJ. mSin3A regulates murine erythroleukemia cell differentiation through association
with the TAL1 (or SCL) transcription factor. Mol Cell Biol, 20(6), 2248-59, 2000. PMCID:110841
Huang, S, Qiu, Y, Shi, Y, Xu, Z, Brandt, SJ. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix
transcription factor TAL1/SCL. EMBO J, 19(24), 6792-803, 2000. PMCID:305888
Ikpeazu, C, Davidson, MK, Halteman, D, Browning, PJ, Brandt, SJ. Donor origin of circulating endothelial progenitors after allogeneic bone marrow
transplantation. Biol Blood Marrow Transplant, 6(3A), 301-8, 2000.
Hasty, AH, Linton, MF, Brandt, SJ, Babaev, VR, Gleaves, LA, Fazio, S. Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery
wall reduces early foam cell lesion formation. Circulation, 99(19), 2571-6, 1999.
Huang, S, Qiu, Y, Stein, RW, Brandt, SJ. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene, 18(35), 4958-67, 1999.
Tang, T, Prasad, KS, Koury, MJ, Brandt, SJ. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation
of the TAL1/SCL transcription factor in murine proerythroblasts. Biochem J, 343 Pt 3, 615-20, 1999. PMCID:1220593
Barbosa, MD, Barrat, FJ, Tchernev, VT, Nguyen, QA, Mishra, VS, Colman, SD, Pastural, E, Dufourcq-Lagelouse, R, Fischer, A, Holcombe, RF, Wallace, MR, Brandt, SJ, de Saint Basile, G, Kingsmore, SF. Identification of mutations in two major mRNA isoforms of the Chediak-Higashi
syndrome gene in human and mouse. Hum Mol Genet, 6(7), 1091-8, 1997.
Drake, CJ, Brandt, SJ, Trusk, TC, Little, CD. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines
a dorsal-to-ventral gradient of vasculogenesis. Dev Biol, 192(1), 17-30, 1997.
Prasad, KS, Brandt, SJ. Target-dependent effect of phosphorylation on the DNA binding activity of the
TAL1/SCL oncoprotein. J Biol Chem, 272(17), 11457-62, 1997.
Barbosa, MD, Nguyen, QA, Tchernev, VT, Ashley, JA, Detter, JC, Blaydes, SM, Brandt, SJ, Chotai, D, Hodgman, C, Solari, RC, Lovett, M, Kingsmore, SF. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature, 382(6588), 262-5, 1996.
Prasad, KS, Jordan, JE, Koury, MJ, Bondurant, MC, Brandt, SJ. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation
of its protein products. J Biol Chem, 270(19), 11603-11, 1995.
Kallianpur, AR, Jordan, JE, Brandt, SJ. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and
vascular systems during embryogenesis. Blood, 83(5), 1200-8, 1994.
Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, and Blaese RM. Fibrosarcoma cells transduced with the IL-6 gene exhibit reduced tumorigenicity, increased immunogenicity and decreased metastatic potential. Cancer Research, 52, 6020-6024, 1992.
Sorrentino, BP, Brandt, SJ, Bodine, D, Gottesman, M, Pastan, I, Cline, A, Nienhuis, AW. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer
of human MDR1. Science, 257(5066), 99-103, 1992.
Bodine, DM, McDonagh, KT, Brandt, SJ, Ney, PA, Agricola, B, Byrne, E, Nienhuis, AW. Development of a high-titer retrovirus producer cell line capable of gene transfer
into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci U S A, 87(10), 3738-42, 1990. PMCID:53978
Brandt, SJ, Bodine, DM, Dunbar, CE, Nienhuis, AW. Retroviral-mediated transfer of interleukin-6 into hematopoietic cells of mice
results in a syndrome resembling Castleman''s disease. Curr Top Microbiol Immunol, 166, 37-41, 1990.
Brandt, SJ, Bodine, DM, Dunbar, CE, Nienhuis, AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman''s
disease in mice. J Clin Invest, 86(2), 592-9, 1990. PMCID:296765
Ramakrishnan, S, Xu, FJ, Brandt, SJ, Niedel, JE, Bast, RC, Brown, EL. Constitutive production of macrophage colony-stimulating factor by human ovarian
and breast cancer cell lines. J Clin Invest, 83(3), 921-6, 1989. PMCID:303767
Brandt, SJ, Peters, WP, Atwater, SK, Kurtzberg, J, Borowitz, MJ, Jones, RB, Shpall, EJ, Bast, RC, Gilbert, CJ, Oette, DH. Effect of recombinant human granulocyte-macrophage colony-stimulating factor
on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med, 318(14), 869-76, 1988.
Le, PT, Kurtzberg, J, Brandt, SJ, Niedel, JE, Haynes, BF, Singer, KH. Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating
factors. J Immunol, 141(4), 1211-7, 1988.
Brandt, SJ, Niedel, JE, Bell, RM, Young, WS. Distinct patterns of expression of different protein kinase C mRNAs in rat
tissues. Cell, 49(1), 57-63, 1987.
Brandt, SJ, Dougherty, RW, Lapetina, EG, Niedel, JE. Pertussis toxin inhibits chemotactic peptide-stimulated generation of inositol
phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells. Proc Natl Acad Sci U S A, 82(10), 3277-80, 1985. PMCID:397758
Pember, SO, Barnes, KC, Brandt, SJ, Kinkade, JM. Density heterogeneity of neutrophilic polymorphonuclear leukocytes: gradient
fractionation and relationship to chemotactic stimulation. Blood, 61(6), 1105-15, 1983.
Brandt, SJ, Barnes, KC, Glass, DB, Kinkade, JM. Glucocorticoid-stimulated increase in chemotactic peptide receptors on differentiating
human myeloid leukemia (HL-60) cells. Cancer Res, 41(12 Pt 1), 4947-51, 1981.
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright © 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.